| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |